• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[治疗性红细胞单采术:技术要点与临床应用]

[Therapeutic erythrocytapheresis: technical aspects and clinical applications].

作者信息

Poullin P, Lefèvre P

机构信息

Service d'hémaphérèse et d'autotransfusion, hôpital de la Conception, 13385 Marseille cedex 05, France.

出版信息

Rev Med Interne. 2008 Apr;29(4):290-6. doi: 10.1016/j.revmed.2007.10.406. Epub 2007 Nov 20.

DOI:10.1016/j.revmed.2007.10.406
PMID:18280010
Abstract

PURPOSE

Therapeutic erythrocytapheresis is a selective red cell-depletion aphaeresis technique.

CURRENT KNOWLEDGE AND KEY POINT

Using a discontinuous or continuous flow blood cell separator, the technique safely allows quickly and automatically collecting a large volume of red cells. The main obstacle of implementation is a poor peripheral venous access. The procedure is well-tolerated. Polycythemia vera, hereditary hemochromatosis, complicated sickle-cell-disease and retinal venous occlusion are the main clinical applications.

PROSPECT AND PROJECT

Therapeutic erythrocytapheresis is a more modern and more effective method than the classic patient-bleeding. It has to be preferred in the early treatment of patients with polycythemia vera and hereditary hemochromatosis.

摘要

目的

治疗性红细胞单采术是一种选择性红细胞去除单采技术。

当前认知与要点

使用间断或连续流动血细胞分离仪,该技术能安全、快速且自动地采集大量红细胞。实施的主要障碍是外周静脉通路不佳。该操作耐受性良好。真性红细胞增多症、遗传性血色素沉着症、复杂镰状细胞病和视网膜静脉阻塞是主要临床应用。

前景与规划

治疗性红细胞单采术是一种比传统患者放血更现代、更有效的方法。在真性红细胞增多症和遗传性血色素沉着症患者的早期治疗中应优先选用。

相似文献

1
[Therapeutic erythrocytapheresis: technical aspects and clinical applications].[治疗性红细胞单采术:技术要点与临床应用]
Rev Med Interne. 2008 Apr;29(4):290-6. doi: 10.1016/j.revmed.2007.10.406. Epub 2007 Nov 20.
2
Survey on the usage of therapeutic erythrocytapheresis in transfusion services in Italy for the treatment of polycythemia vera, secondary erythrocytosis and hemochromatosis.
Transfus Apher Sci. 2023 Oct;62(5):103752. doi: 10.1016/j.transci.2023.103752. Epub 2023 Jun 21.
3
The efficiency of therapeutic erythrocytapheresis compared to phlebotomy: a mathematical tool for predicting response in hereditary hemochromatosis, polycythemia vera, and secondary erythrocytosis.治疗性红细胞单采术与放血疗法的疗效比较:一种预测遗传性血色素沉着症、真性红细胞增多症和继发性红细胞增多症反应的数学工具。
J Clin Apher. 2014 Jun;29(3):133-8. doi: 10.1002/jca.21303. Epub 2013 Oct 15.
4
Clinical application of therapeutic erythrocytapheresis (TEA).治疗性红细胞单采术(TEA)的临床应用。
Transfus Sci. 2000 Jun;22(3):183-94. doi: 10.1016/s0955-3886(00)00042-4.
5
Therapeutic erythrocytapheresis in the initial treatment of hereditary hemochromatosis.
Acta Medica (Hradec Kralove). 2012;55(4):180-5. doi: 10.14712/18059694.2015.43.
6
Erythrocytapheresis versus phlebotomy in the maintenance treatment of HFE hemochromatosis patients: results from a randomized crossover trial.红细胞单采术与放血疗法用于HFE型血色素沉着症患者维持治疗的比较:一项随机交叉试验的结果
Transfusion. 2016 Jan;56(1):261-70. doi: 10.1111/trf.13328. Epub 2015 Sep 10.
7
Pinch-off syndrome in patients with sickle cell disease receiving erythrocytapheresis.接受红细胞单采术的镰状细胞病患者的夹闭综合征
Pediatr Blood Cancer. 2008 Feb;50(2):354-6. doi: 10.1002/pbc.21058.
8
Erythrocytapheresis therapy to reduce iron overload in chronically transfused patients with sickle cell disease.红细胞单采术治疗镰状细胞病慢性输血患者以减轻铁过载。
Blood. 1994 Feb 15;83(4):1136-42.
9
The efficiency of therapeutic erythrocytapheresis compared to phlebotomy in relation to blood volume and delta-hematocrit: an evaluation in hereditary hemochromatosis polycythemia vera and secondary erythrocytosis.与放血疗法相比,治疗性红细胞单采术在血容量和红细胞压积变化方面的效率:对遗传性血色素沉着症、真性红细胞增多症和继发性红细胞增多症的评估
Transfus Apher Sci. 2013 Apr;48(2):187. doi: 10.1016/j.transci.2013.02.030. Epub 2013 Mar 13.
10
[Blood rheologic disorders in patients with polycythemia vera and their correction by therapeutic erythrocytapheresis].
Gematol Transfuziol. 1989 Nov;34(11):33-6.

引用本文的文献

1
Hemodilution therapy using automated erythrocytapheresis in central retinal vein occlusion: results of a multicenter randomized controlled study.应用全自动红细胞分离术进行血液稀释疗法治疗视网膜中央静脉阻塞:一项多中心随机对照研究结果。
Graefes Arch Clin Exp Ophthalmol. 2011 Apr;249(4):505-12. doi: 10.1007/s00417-010-1532-5. Epub 2010 Oct 17.